IRIS
BOVIS, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.155
AS - Asia 2.384
NA - Nord America 2.094
Continente sconosciuto - Info sul continente non disponibili 653
SA - Sud America 206
AF - Africa 45
OC - Oceania 7
Totale 21.544
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.788
US - Stati Uniti d'America 1.932
SG - Singapore 872
CN - Cina 535
BD - Bangladesh 384
VN - Vietnam 336
FR - Francia 145
BR - Brasile 126
HK - Hong Kong 89
CA - Canada 68
DE - Germania 47
FI - Finlandia 40
GB - Regno Unito 40
AR - Argentina 25
MX - Messico 25
IQ - Iraq 24
EC - Ecuador 20
IN - India 20
JM - Giamaica 20
JP - Giappone 19
NL - Olanda 17
ID - Indonesia 16
CO - Colombia 13
CR - Costa Rica 13
ES - Italia 12
CH - Svizzera 11
TR - Turchia 11
ZA - Sudafrica 11
SA - Arabia Saudita 10
PH - Filippine 9
PK - Pakistan 9
KE - Kenya 8
RU - Federazione Russa 8
CL - Cile 7
DZ - Algeria 7
MA - Marocco 7
AU - Australia 6
MY - Malesia 6
SE - Svezia 6
TH - Thailandia 6
GT - Guatemala 5
IE - Irlanda 5
NI - Nicaragua 5
PT - Portogallo 5
JO - Giordania 4
NP - Nepal 4
PE - Perù 4
PR - Porto Rico 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
UA - Ucraina 4
UZ - Uzbekistan 4
VE - Venezuela 4
BZ - Belize 3
GR - Grecia 3
HN - Honduras 3
PS - Palestinian Territory 3
RS - Serbia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AL - Albania 2
AT - Austria 2
BB - Barbados 2
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
PL - Polonia 2
QA - Qatar 2
RO - Romania 2
TN - Tunisia 2
VG - Isole Vergini Britanniche 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
Totale 20.887
Salva come PNG Salva come JPEG
Città #
Genova 7.940
Genoa 4.682
Vado Ligure 1.472
Rapallo 1.376
Singapore 410
San Jose 407
Ashburn 274
Council Bluffs 145
Lauterbourg 127
Ho Chi Minh City 109
New York 102
Beijing 100
Hanoi 89
Hong Kong 84
Santa Clara 55
Los Angeles 46
Bordighera 40
Milan 33
Frankfurt am Main 32
Helsinki 32
Rome 29
Buffalo 25
Dallas 22
Tianjin 21
Chicago 20
São Paulo 18
Toronto 18
Philadelphia 17
Tokyo 17
Da Nang 16
Haiphong 16
Boardman 15
Mexico City 15
Kingston 13
Naples 13
St Louis 13
Brooklyn 11
Atlanta 10
Baghdad 10
Montreal 10
Phoenix 10
Hải Dương 9
London 9
Amsterdam 8
Charlotte 8
Florence 8
Lappeenranta 8
Orem 8
San José 8
The Bronx 8
Washington 8
Zurich 8
Bari 7
Cardiff 7
City of London 7
Denver 7
Las Vegas 7
Rochester 7
San Francisco 7
Guayaquil 6
Houston 6
Jakarta 6
Memphis 6
Miami 6
Nairobi 6
Pasadena 6
Riyadh 6
Turin 6
Bologna 5
Can Tho 5
Chesapeake 5
Columbus 5
Dhaka 5
Fort Myers 5
Jacksonville 5
Johannesburg 5
Miano 5
Nashville 5
San Diego 5
Alexandria 4
Amman 4
Austin 4
Berlin 4
Calgary 4
Campinas 4
Dublin 4
Guatemala City 4
Manchester 4
Medford 4
Newark 4
Palermo 4
Paris 4
Portland 4
Quito 4
Reggio Emilia 4
San Juan 4
Santiago 4
Seattle 4
Verona 4
Alajuela 3
Totale 18.225
Salva come PNG Salva come JPEG
Nome #
Bloodstream infections in patients living with HIV in the modern cART era 229
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis 216
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 215
Delineating the application of ultrasound in detecting synovial abnormalities of subtalar joint in juvenile idiopathic arthritis 211
The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 207
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 205
Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology 202
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative 201
The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 199
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 191
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 185
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 182
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 182
The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 179
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis 177
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis 174
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. 172
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 172
Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care 172
The Canadian English and French versions of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 172
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 169
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 165
Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas 162
Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy 161
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis 160
Vascular factors predict polyneuropathy in a non-diabetic elderly population 160
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 160
Outpatient erbium:YAG (2940 nm) laser treatment for snoring: a prospective study on 40 patients 159
Non-invasive mitochondrial DNA quantification on day 3 predicts blastocyst development: a prospective, blinded, multi-centric study 158
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 158
The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 156
The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 156
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 156
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 155
The Bulgarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 154
Defining criteria for disease activity States in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. 152
Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study 151
The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 150
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 150
The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
The Omani Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
Classification criteria for autoinflammatory recurrent fevers 148
Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome 148
The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 147
The Colombian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 146
The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 146
The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
A long-term prognostic value of CT angiography and exercise ECG in patients with suspected CAD 145
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. 144
The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
The Afrikaans version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 142
The Latvian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 142
The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 142
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data 142
The Hindi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 141
The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 141
The Swiss French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
The Mexican Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 136
The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 136
Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. 135
The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 135
The Farsi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 135
The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis 133
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS 132
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 131
The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 131
The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 129
The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 129
The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 128
Revised upper limb module for spinal muscular atrophy: 12 month changes 128
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 128
The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 127
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 126
Coronary in-stent restenosis: Assessment with CT coronary angiography 126
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients 126
The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 125
The Libyan Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 125
The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 124
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 124
Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease 121
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 121
The Greek version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 120
Role of Alveolar β2-Adrenergic Receptors on Lung Fluid Clearance and Exercise Ventilation in Healthy Humans 120
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 119
A data-driven model of disability progression in progressive multiple sclerosis 119
Occurrence of smooth endoplasmic reticulum aggregates in metaphase II oocytes: relationship with stimulation protocols and outcome of ICSI and IVF cycles 118
Aortic annulus area assessment by multidetector computed tomography for predicting paravalvular regurgitation in patients undergoing balloon-expandable transcatheter aortic valve implantation: A comparison with transthoracic and transesophageal echocardiography 117
Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF) 116
Totale 15.029
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.973
article - articoli 76.237
book - libri 0
conference - conferenze 533
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 203
Totale 153.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.493 95 44 83 121 38 148 54 309 148 173 62 218
2022/20231.661 148 157 24 157 222 269 20 132 297 49 154 32
2023/20241.019 41 122 37 117 73 142 92 57 70 63 81 124
2024/20253.342 98 247 127 229 494 428 355 456 124 151 270 363
2025/20266.473 686 192 489 374 747 489 849 281 526 642 514 684
2026/2027596 596 0 0 0 0 0 0 0 0 0 0 0
Totale 21.544